OUR PRODUCTS

MOBILE APPS

GENERAL INFO

IGMS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

IGM Biosciences (IGMS) Earnings Date & Reports

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IGMS is expected to report earnings to fall 107.59% to -11 cents per share on November 06

IGM Biosciences IGMS Stock Earnings Reports

Q3'25

Est.

$-0.12

Q2'25

Beat

by $1.70

Q1'25

Missed

by $0.40

Q4'24

Beat

by $0.13

Q3'24

Missed

by $0.21

The last earnings report on August 11 showed earnings per share of $1.58, beating the estimate of -11 cents. With 9.91K shares outstanding, the current market capitalization sits at 76.57M.

View a ticker or compare two or three

Compare

IGMS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IGMS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IGMS showed earnings on August 11, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a biotechnology company, which develops antibodies for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

325 East Middlefield Road

Phone

+1 650 965-7873

Employees

224

Web

https://www.igmbio.com